Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma

R. Venkatramani, J. E. Stein, A. Sapra, Y. Genyk, V. Jhaveri, Marcio Malogolowkin, L. Mascarenhas

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background The potential for surgical resection of primary hepatoblastoma tumours was assessed at diagnosis, and after two and four cycles of neoadjuvant chemotherapy. Justified in selected patients

Methods Available radiographic images for patients with stage III and IV hepatoblastoma diagnosed between 1991 and 2008 were reviewed. The extent of disease was determined at diagnosis using the PRETEXT staging system, and after two and four cycles of therapy by POST-TEXT staging. Tumour resectability based on radiographic studies was assessed independently by two surgeons with expertise in hepatic surgery who were blinded to treatment and clinical outcome.

Results Radiographic images from 20 patients with hepatoblastoma were reviewed. Six of 20 tumours were downstaged after two cycles, and three additional tumours were downstaged following four cycles. All PRETEXT stage III and IV tumours were determined to be surgically unresectable at diagnosis. The number of tumours considered unresectable decreased from 16 of 20 at diagnosis to seven of 20 after two cycles, and to four of 20 after four cycles. Five of the seven tumours that were unresectable after two cycles, and all four tumours that were unresectable after four cycles would have qualified for liver transplant based on radiographic studies.

Conclusion The majority of stage III and IV hepatoblastomas achieved radiographic resectability after two cycles of chemotherapy. There may be an opportunity for earlier surgical intervention and potential for a reduction in chemotherapy in a considerable number of patients. Two cycles may be enough

Original languageEnglish (US)
Pages (from-to)108-113
Number of pages6
JournalBritish Journal of Surgery
Volume102
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Hepatoblastoma
Drug Therapy
Neoplasms
Liver
Transplants

ASJC Scopus subject areas

  • Surgery

Cite this

Venkatramani, R., Stein, J. E., Sapra, A., Genyk, Y., Jhaveri, V., Malogolowkin, M., & Mascarenhas, L. (2015). Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. British Journal of Surgery, 102(1), 108-113. https://doi.org/10.1002/bjs.9681

Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. / Venkatramani, R.; Stein, J. E.; Sapra, A.; Genyk, Y.; Jhaveri, V.; Malogolowkin, Marcio; Mascarenhas, L.

In: British Journal of Surgery, Vol. 102, No. 1, 01.01.2015, p. 108-113.

Research output: Contribution to journalArticle

Venkatramani, R, Stein, JE, Sapra, A, Genyk, Y, Jhaveri, V, Malogolowkin, M & Mascarenhas, L 2015, 'Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma', British Journal of Surgery, vol. 102, no. 1, pp. 108-113. https://doi.org/10.1002/bjs.9681
Venkatramani, R. ; Stein, J. E. ; Sapra, A. ; Genyk, Y. ; Jhaveri, V. ; Malogolowkin, Marcio ; Mascarenhas, L. / Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. In: British Journal of Surgery. 2015 ; Vol. 102, No. 1. pp. 108-113.
@article{14b29009298d4e07bca40eff51d55b60,
title = "Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma",
abstract = "Background The potential for surgical resection of primary hepatoblastoma tumours was assessed at diagnosis, and after two and four cycles of neoadjuvant chemotherapy. Justified in selected patientsMethods Available radiographic images for patients with stage III and IV hepatoblastoma diagnosed between 1991 and 2008 were reviewed. The extent of disease was determined at diagnosis using the PRETEXT staging system, and after two and four cycles of therapy by POST-TEXT staging. Tumour resectability based on radiographic studies was assessed independently by two surgeons with expertise in hepatic surgery who were blinded to treatment and clinical outcome.Results Radiographic images from 20 patients with hepatoblastoma were reviewed. Six of 20 tumours were downstaged after two cycles, and three additional tumours were downstaged following four cycles. All PRETEXT stage III and IV tumours were determined to be surgically unresectable at diagnosis. The number of tumours considered unresectable decreased from 16 of 20 at diagnosis to seven of 20 after two cycles, and to four of 20 after four cycles. Five of the seven tumours that were unresectable after two cycles, and all four tumours that were unresectable after four cycles would have qualified for liver transplant based on radiographic studies.Conclusion The majority of stage III and IV hepatoblastomas achieved radiographic resectability after two cycles of chemotherapy. There may be an opportunity for earlier surgical intervention and potential for a reduction in chemotherapy in a considerable number of patients. Two cycles may be enough",
author = "R. Venkatramani and Stein, {J. E.} and A. Sapra and Y. Genyk and V. Jhaveri and Marcio Malogolowkin and L. Mascarenhas",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/bjs.9681",
language = "English (US)",
volume = "102",
pages = "108--113",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma

AU - Venkatramani, R.

AU - Stein, J. E.

AU - Sapra, A.

AU - Genyk, Y.

AU - Jhaveri, V.

AU - Malogolowkin, Marcio

AU - Mascarenhas, L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background The potential for surgical resection of primary hepatoblastoma tumours was assessed at diagnosis, and after two and four cycles of neoadjuvant chemotherapy. Justified in selected patientsMethods Available radiographic images for patients with stage III and IV hepatoblastoma diagnosed between 1991 and 2008 were reviewed. The extent of disease was determined at diagnosis using the PRETEXT staging system, and after two and four cycles of therapy by POST-TEXT staging. Tumour resectability based on radiographic studies was assessed independently by two surgeons with expertise in hepatic surgery who were blinded to treatment and clinical outcome.Results Radiographic images from 20 patients with hepatoblastoma were reviewed. Six of 20 tumours were downstaged after two cycles, and three additional tumours were downstaged following four cycles. All PRETEXT stage III and IV tumours were determined to be surgically unresectable at diagnosis. The number of tumours considered unresectable decreased from 16 of 20 at diagnosis to seven of 20 after two cycles, and to four of 20 after four cycles. Five of the seven tumours that were unresectable after two cycles, and all four tumours that were unresectable after four cycles would have qualified for liver transplant based on radiographic studies.Conclusion The majority of stage III and IV hepatoblastomas achieved radiographic resectability after two cycles of chemotherapy. There may be an opportunity for earlier surgical intervention and potential for a reduction in chemotherapy in a considerable number of patients. Two cycles may be enough

AB - Background The potential for surgical resection of primary hepatoblastoma tumours was assessed at diagnosis, and after two and four cycles of neoadjuvant chemotherapy. Justified in selected patientsMethods Available radiographic images for patients with stage III and IV hepatoblastoma diagnosed between 1991 and 2008 were reviewed. The extent of disease was determined at diagnosis using the PRETEXT staging system, and after two and four cycles of therapy by POST-TEXT staging. Tumour resectability based on radiographic studies was assessed independently by two surgeons with expertise in hepatic surgery who were blinded to treatment and clinical outcome.Results Radiographic images from 20 patients with hepatoblastoma were reviewed. Six of 20 tumours were downstaged after two cycles, and three additional tumours were downstaged following four cycles. All PRETEXT stage III and IV tumours were determined to be surgically unresectable at diagnosis. The number of tumours considered unresectable decreased from 16 of 20 at diagnosis to seven of 20 after two cycles, and to four of 20 after four cycles. Five of the seven tumours that were unresectable after two cycles, and all four tumours that were unresectable after four cycles would have qualified for liver transplant based on radiographic studies.Conclusion The majority of stage III and IV hepatoblastomas achieved radiographic resectability after two cycles of chemotherapy. There may be an opportunity for earlier surgical intervention and potential for a reduction in chemotherapy in a considerable number of patients. Two cycles may be enough

UR - http://www.scopus.com/inward/record.url?scp=84919387887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919387887&partnerID=8YFLogxK

U2 - 10.1002/bjs.9681

DO - 10.1002/bjs.9681

M3 - Article

C2 - 25349947

AN - SCOPUS:84919387887

VL - 102

SP - 108

EP - 113

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 1

ER -